无锡航亚科技股份有限公司 关于公司 2024 年度提质增效重回报专项行动方案的 半年度评估报告 无锡航亚科技股份有限公司（以下简称"公司"）致力于依靠科技进步和 管理创新不断提高核心竞争力，以组织发展体系建设为驱动，推动软实力和硬 指标共同进阶，落实打造长期、稳定、可持续的投资者价值回报机制。基于对 未来发展的坚定信心，及对投资者高度负责的精神，公司制定了《无锡航亚科 技股份有限公司 2024 年度"提质增效重回报"行动方案》（以下简称"行动方 案"），努力实现经营业绩持续稳定的增长，为客户、股东、员工及其他社会各 方创造价值，积极回报利益相关方。 2024 年上半年，行动方案主要举措的落实（进展）及成效情况如下： 一、提质增效有进展 2024 年上半年，航空和医疗骨科各业务板块继续保持比较良好的发展态势， 公司实现营业收入 33,961.41 万元，同比增长 32.84%；实现归母净利润 6,721.07 万元，同比增长 97.76%，收入与净利润齐创历史新高，总体运营质量继续得到 改善提升。预计 2024 年全年将继续保持较快、较好的增长趋势。 1.航空发动机叶片业务稳健增长。（1）募投建设的压气机叶片车 ...

证券代码：688510 证券简称：航亚科技 公告编号：2024-043 无锡航亚科技股份有限公司 2024年半年度募集资金存放与实际使用情况专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集 资金管理和使用的监管要求（2022 年修订）》《上海证券交易所科创板上市公司 自律监管指引第 1 号——规范运作（2023 年 12 月修订）》及《上海证券交易所 上市公司自律监管指南第 1 号——公告格式（2024 年 5 月修订）》等有关规定， 无锡航亚科技股份有限公司（以下简称"公司"）将 2024 年半年度募集资金存放 与实际使用情况说明如下： 一、募集资金基本情况 （一）实际募集资金金额及资金到账情况 经中国证券监督管理委员会《关于同意无锡航亚科技股份有限公司首次公开 发行股票注册的批复》（证监许可[2020]2767 号）同意，本公司由华泰联合证券 有限公司、光大证券股份有限公司联合承销采用网下询价配售与网上资金申购定 价发行相结合的方式发行人民 ...

证券代码：688510 证券简称：航亚科技 公告编号：2024-040 无锡航亚科技股份有限公司关于持股 5%以上股东 减持股份结果暨权益变动超过 1%的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持股的基本情况 本次减持计划实施前，无锡航亚科技股份有限公司（以下简称"公司"）董事 阮仕海先生持有公司股份 21,884,091 股，占公司总股本的 8.47%，上述股份为公 司首次公开发行前取得股份，且于 2023 年 12 月 16 日解除限售并上市流通。 减持计划的实施结果情况 2024 年 6 月 1 日，公司在上海证券交易所网站（www.see.com.cn）披露了《无 锡航亚科技股份有限公司董事减持股份计划公告》（公告编号：2024-035）。公司 董事阮仕海先生拟通过大宗交易的方式减持其所持有的公司股份合计不超过 4,909,269 股，即不超过公司股份总数的 1.90%。 | | 股东名称 | 持股数量（股） | 持股比例 | 一致行动关系形成原因 | | --- | ...

Financial Performance - Revenue in 2023 reached 543,505,433.12 RMB, a 49.93% increase compared to 2022[1] - Net profit attributable to shareholders in 2023 was 90,201,290.73 RMB, a 349.61% increase compared to 2022[1] - Total revenue for 2023 reached 543.51 million yuan, a 49.93% increase year-on-year, with operating costs rising by 36.51% to 347.92 million yuan[135] - Net cash flow from operating activities surged by 132% to 120.73 million yuan, while net cash flow from financing activities decreased by 75.90% to -6.53 million yuan[135] - The company achieved annual revenue of 543.51 million yuan, a year-on-year increase of 49.93%, and net profit attributable to the parent company of 90.20 million yuan, a year-on-year increase of 349.61%[106] - Revenue increased by 49.93% year-over-year, driven by stable growth in both international and domestic business[181] - Net profit attributable to parent company owners surged by 349.61%, with basic and diluted earnings per share up by 337.50%[181] - Operating cash flow increased by 132% due to higher revenue and improved collection of receivables[182] - Q4 revenue reached 144.2 million RMB, with net profit attributable to shareholders at 20.7 million RMB[183] - Full-year revenue for 2023 was 543.51 million RMB, a 49.93% increase, with net profit at 90.2 million RMB, up 349.61%[187] International Business Growth - International engine parts business revenue in 2023 was 269.98 million RMB, accounting for 49.67% of total revenue, a 68.27% increase compared to 2022[7] - The company's international business revenue increased by 64.87% year-on-year, reaching 278.78 million yuan, with a gross profit margin of 41.25%[121] - International aero-engine parts business revenue increased significantly to 269.98 million yuan, up 68.27% year-on-year, accounting for 49.67% of total revenue (44.26% in 2022)[123] - Revenue from Customer 1 for engine blades grew by 53.02% to 237.16 million yuan, accounting for 87.84% of total aero-engine parts revenue[123] - Revenue from Customer 4 for engine blades surged by 648.33% to 18.56 million yuan, while revenue from Customer 6 increased by 709.53% to 7.15 million yuan[123] - Export revenue accounted for 51.77% of total revenue at 278.78 million yuan, with potential risks from RMB exchange rate fluctuations[143] - The company's sales revenue from aviation business overseas customers increased by 68.27% year-on-year, reaching 109.53 million yuan[120] - The company's sales revenue from its largest overseas customer, Safran, increased by 53.02% year-on-year, reaching 237.16 million yuan[120] Domestic Business Growth - Domestic engine parts business grew by 33.48% in 2023[9] - The company's revenue from related party China Aero Engine Group reached 198.5974 million yuan, accounting for 36.88% of the total revenue[89] - The company's accounts receivable amounted to 181.9864 million yuan, a year-on-year increase of 15.72%, and notes receivable amounted to 82.7285 million yuan, a year-on-year increase of 90.45%[103] - The company's accounts receivable are primarily from domestic aerospace business, with 98.20% of receivables within one year, indicating a low credit risk[103] R&D and Technological Advancements - The company's R&D center is nearing completion, with new capabilities in special welding and non-destructive testing[14] - The company has successfully developed multiple types of civil aviation engine compressor blades for international markets[16] - The company is deeply involved in the development of domestic commercial aviation engines and key component production[16] - The company has introduced new gas turbine key component products[16] - The company has mastered advanced engineering manufacturing technologies for various materials and special processes, including titanium and superalloy hot working parameters[28] - The company is conducting functional verification and parameter iteration tests for inertial friction welding equipment, indicating progress in innovation and new technology development[37] - The company is involved in the development of high-performance components for aero-engines and gas turbines, focusing on advanced precision machining, testing, and special process technologies[55] - The company has 96 R&D personnel, accounting for 15.51% of the total workforce, with total R&D personnel compensation reaching 19.28 million yuan and an average salary of 200,900 yuan[69] Aerospace and Aviation Business - The company's Leap engine continues to gain market share in single-aisle aircraft, with increasing supply for the Leap-1C due to rising C919 orders[23] - The company signed a long-term cooperation agreement with Safran for the GENX next-gen engine project in June 2023, with partial product approvals completed and mass production expected in H2 2024[23] - The company successfully developed GE90 series engine high-pressure compressor blades in 2023, receiving customer approval for mass production[23] - The company's RR XWB series compressor blade project is in final verification stage and nearing mass production[23] - The company is a major supplier of precision forged low-pressure compressor blades for Safran, with over 210 types of blades developed for various engine models[32] - The company participates in key Chinese engine projects including CJ-1000/CJ-2000 for C919/CR929 aircraft, providing high and low pressure compressor blades[32] - The company is a supplier to major domestic and international aero-engine manufacturers, including Safran, China Aero Engine Group, GE Aviation, and Rolls-Royce, as well as domestic gas turbine companies such as China Aero Engine Gas Turbine and Longjiang Guanghan[38] - The company's aviation business revenue increased by 50.86% year-on-year, reaching 484.44 million yuan, with a gross profit margin of 35.62%[121] - Aero-engine business accounted for 89.96% of total revenue, while medical business accounted for 10.04%, with the top five customers contributing 97.03% and 89.01% respectively[133] - The company renewed a long-term supply agreement with Customer 1, increasing the average share of compressor blade products to over 50% from 2023 to 2030, with a 41.02% increase in blade deliveries in 2023[125] Medical Business - The company has become a leading domestic supplier of medical orthopedic implant forgings, achieving mass production of hip joint products and localization of titanium alloy tibial platforms[33] - The company serves major medical device companies including Johnson & Johnson, Smith & Nephew, and Weigao Orthopedic, and established new partnerships with Dabo Medical, Tianjin Just, and Mindray Orthopedics in 2023[33] - The company is expanding its international orthopedic market presence with initial success[33] - The company has entered the medical orthopedic implant forging field, producing products such as artificial hip joint femoral stems, acetabular cups, knee joint tibial trays, and trauma plates[40] - The company's medical business revenue increased by 37.20% year-on-year, reaching 54.05 million yuan, with a gross profit margin of 34.76%[121] - Medical business overseas revenue grew by 1.85% to 88.04 million yuan, with three new customers added during the year[132] - Medical orthopedic joint business revenue grew by 37.20%, with further optimization of product structure[192] Operational Efficiency and Management - The company has implemented lean management activities to improve production efficiency and capacity utilization[12] - The company has launched a digital, automated, and intelligent upgrade project to enhance operational levels and core competitiveness[14] - The company's digital factory construction has significantly improved production efficiency, earning it the title of "Jiangsu Province Demonstration Smart Workshop"[84] - The company's management team, led by Chairman Yan Qi, has extensive experience in large state-owned enterprises and listed companies, contributing to its strategic and operational strengths[79] - The company's inventory book value at the end of the reporting period was 155.82 million yuan, with all major inventory items corresponding to sales orders[104] Certifications and Partnerships - The company has obtained NADCAP certification for five major categories of special processes, including heat treatment, chemical treatment, non-destructive testing, surface strengthening, and metal material manufacturing (forging), and has received certifications from Safran, GE Aviation, and Rolls-Royce[37] - The company has obtained multiple international certifications, including ISO13485, AS9100D, and NADCAP, enhancing its competitive advantage in the aerospace and medical fields[84] - The company has established strong partnerships with major clients such as Safran, GE Aviation, Rolls-Royce, and Johnson & Johnson, ensuring stable and long-term cooperation[78] Market and Industry Outlook - The domestic aero-engine market is expected to reach 1.1 trillion yuan by 2026, with the military aero-engine market projected to reach 330 billion yuan, driven by new aircraft models and engine upgrades[47] - The company is a key participant in the development of domestic aero-engine and gas turbine components, collaborating with major domestic research units and undertaking tasks for advanced engine development[53] - The company is actively participating in the domestic commercial aero-engine development and promoting the localization of gas turbines[55] - The company's international business has not been materially affected by being listed on the U.S. MEU list, but future uncertainties in international relations could impact business sustainability[111] Investment and Projects - Leap compressor blade manufacturing and forging process integration industrialization project has completed internal process development and customer validation, with a cumulative investment of 305 million yuan[71] - GE90 high-pressure blade new process development and industrialization project has entered small batch trial production with a total investment of 120 million yuan[71] - GENX-1B series compressor blade development project has completed the first batch production of 3 levels with a total investment of 400 million yuan[71] - Rolls-Royce precision forging blade transfer project has fully verified 13 rotor series parts with a cumulative investment of 1,047 million yuan[71] - RRTrent1000 medium-pressure blade development and industrialization project has completed process design and mold verification with a total investment of 1,070 million yuan[71] - RR Athena ring transfer project has entered mass production stage with a cumulative investment of 410 million yuan[72] - CJ2000AX fan disk inertial friction welding component machining process development project has completed post-welding machining development with a cumulative investment of 406 million yuan[72] - Domestic commercial engine high-pressure compressor precision forging blade development project has completed development and delivery with a cumulative investment of 100 million yuan[72] - QD70 compressor rotor and stator blade development project has completed development and delivery with a cumulative investment of 285 million yuan[73] - Inertial friction welding capability development project has completed high-temperature alloy disk welding simulation and is conducting titanium alloy ring tests with a cumulative investment of 1,298 million yuan[73] - The company plans to complete the second phase of investment in Guizhou Hangya by August 2024, expanding capacity for casings and ring components[198] Risks and Challenges - The company faces risks from raw material price fluctuations, particularly for titanium alloys and high-temperature alloys, which could impact profitability[94] - The company's high concentration in both aerospace and medical sectors poses a risk if major clients reduce demand due to external factors[89] Dividends and Shareholder Returns - The company plans to distribute a cash dividend of 2 yuan per 10 shares, totaling 51.68 million yuan, representing 53.54% of the parent company's net profit[140] Global Market Performance - Revenue for the fiscal year 2023 reached a record high of $96.77 billion, driven by strong performance in the Chinese market[110] - The company reported a net income of $23.45 billion, representing a 15% increase year-over-year[110] - Total assets grew by 12% to $350.6 billion, with a significant portion attributed to increased investments in R&D[110] - The company's R&D expenditure for 2023 was $18.9 billion, up 20% from the previous year, focusing on new product development and technological advancements[110] - Market expansion efforts resulted in a 25% increase in international sales, contributing $45.3 billion to total revenue[110] - The company completed two major acquisitions, totaling $5.6 billion, aimed at enhancing its product portfolio and market reach[110] - Shareholder equity increased by 18% to $120.4 billion, reflecting strong financial health and investor confidence[110] - The company issued $3 billion in bonds to fund future growth initiatives, with a focus on sustainability and innovation[110] - Earnings per share (EPS) for 2023 stood at $5.67, a 17% increase from the previous year, driven by higher profitability and share buybacks[110] - The company provided a positive outlook for 2024, projecting a revenue growth of 10-12% and an EPS increase of 15-18%[110]

证券代码：688510 证券简称：航亚科技 公告编号：2024-035 无锡航亚科技股份有限公司 董事减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持股的基本情况 截至本公告披露日，无锡航亚科技股份有限公司（以下简称"公司"）董事阮 仕海先生持有公司股份 21,884,091 股，占公司总股本的 8.47%，上述股份为公司 首次公开发行前取得股份，且于 2023 年 12 月 16 日解除限售并上市流通。 一、减持主体的基本情况 1 | | 股东名称 | 持股数量（股） | 持股比例 | 一致行动关系形成原因 | | --- | --- | --- | --- | --- | | 第一组 | 严奇 | 37,317,391 | 14.44% | | | | 阮仕海 | 21,884,091 | 8.47% | | | | 黄勤 | 6,178,261 | 2.39% | 无锡华航科创投资中心 | | | 朱国有 | 4,000,000 | 1.55% | （有限合伙）为公 ...

证券代码：688510 证券简称：航亚科技 公告编号：2024-032 无锡航亚科技股份有限公司 2024 年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股东大会由董事会召集，董事长严奇先生主持，以现场投票和网络投票 相结合的方式进行表决。本次股东大会的召集、召开程序、出席会议人员的资格、 召集人资格、会议的表决程序和表决结果符合《公司法》《证券法》《无锡航亚科 技股份有限公司章程》的规定。 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2024 年 5 月 8 日 （二） 股东大会召开的地点：公司董事会办公室会议室（江苏省无锡市新东安 路 35 号） （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 13 | | --- | --- | | 普通股股东人数 | 13 | | 2、出席会议的股东所持有的表决权数量 | 26,162,621 | | 普 ...

证券代码：688510 证券简称：航亚科技 公告编号：2024-033 根据《上市公司股权激励管理办法》《上海证券交易所科创板股票上市规则》 《科创板上市公司自律监管指南第 4 号——股权激励信息披露》等规范性文件的要 求，公司对本次激励计划内幕信息知情人及激励对象在激励计划草案公告前六个月 内买卖公司股票的情况进行自查，具体情况如下： 无锡航亚科技股份有限公司 关于 2024 年限制性股票激励计划内幕信息知情人 及激励对象买卖公司股票情况的自查报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 无锡航亚科技股份有限公司（以下简称"公司"）于 2024 年 4 月 17 日召开了第 三届董事会第九次会议、第三届监事会第九次会议，审议通过了《关于公司 2024 年限制性股票激励计划（草案）及其摘要的议案》等相关议案，并于 2024 年 4 月 18 日在上海证券交易所网站（www.sse.con.cn）披露了相关公告。 按照《上市公司信息披露管理办法》《无锡航亚科技股份有限公司信息披露管 理制度》及相关制度的规定，公司对 ...

北京植德律师事务所 本所律师参加本次会议进行见证，并根据《中华人民共和国公司法》（以下 简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司股东大会规则》（以下简称"《股东大会规则》"）、《律师事务所 从事证券法律业务管理办法》（以下简称"《证券法律业务管理办法》"）、《律 师事务所证券法律业务执业规则（试行）》（以下简称"《证券法律业务执业规 则》"）等相关法律、行政法规、规章、规范性文件及《无锡航亚科技股份有限 公司章程》（以下简称"《公司章程》"）的规定，就本次会议的召集与召开程 序、召集人资格、出席会议人员资格、会议表决程序及表决结果等事宜，出具本 法律意见书。 对本法律意见书的出具，本所律师特作如下声明： 关于无锡航亚科技股份有限公司 2024 年第一次临时股东大会的 法律意见书 植德京（会）字[2024]0036 号 致：无锡航亚科技股份有限公司（贵公司） 北京植德律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出 席并见证贵公司 2024 年第一次临时股东大会（以下简称"本次会议"）。 1．本所律师仅就本次会议的召集与召开程序、召集人和出席现场会议人员 ...

Investment Rating - The report assigns an "Accumulate" rating to the company based on its performance and growth prospects [2][33]. Core Insights - In 2023, the company achieved operating revenue of 544 million yuan, a year-on-year increase of 49.93%, with a net profit attributable to shareholders of 90 million yuan, up 349.61% year-on-year [3][13]. - The company continues to see stable growth in both international and domestic business segments, with significant improvements in productivity and product quality [4][16]. - The company has signed long-term cooperation agreements with major clients, including a significant increase in the delivery of LEAP engine blades to Safran, with expectations for further growth in 2024 [17][19]. Financial Performance - For 2023, the company reported a gross margin of 35.99%, an increase of 6.29 percentage points year-on-year, and a net profit margin of 16.60%, up 11.06 percentage points year-on-year [22][42]. - The first quarter of 2024 saw operating revenue of 161 million yuan, a year-on-year increase of 41.76%, and a net profit of 32 million yuan, up 153.27% year-on-year [41][22]. - The company’s cash flow from operating activities reached 121 million yuan in 2023, a 132% increase year-on-year, indicating improved cash collection [25]. Business Segments - In 2023, the aviation segment generated 484 million yuan in revenue, accounting for 89.13% of total revenue, with a gross margin of 35.62% [42][16]. - The medical segment achieved revenue of 54 million yuan, growing 37.20% year-on-year, with a gross margin of 34.76% [42][16]. - The domestic engine parts business grew robustly, with a year-on-year increase of 33.48%, and the proportion of parts/batch production business rose significantly from 33% in 2022 to 69% in 2023 [17][44]. Future Outlook - The company has announced a restrictive stock incentive plan for 2024, aiming for net profits of no less than 135 million yuan in 2024, with expected growth rates of 54.32%, 33.33%, and 22.22% for the following years [2][31]. - The forecast for net profit attributable to shareholders for 2024-2026 is 134 million, 180 million, and 225 million yuan, respectively, with corresponding EPS of 0.52, 0.70, and 0.87 yuan [11][33].

Investment Rating - The investment rating for the company is "Buy" with a target price of 27.00 yuan, indicating an expected return of over 10% relative to the CSI 300 index in the next six months [24][34]. Core Insights - The company achieved record-high revenue and profit in 2023, with revenue of 544 million yuan (+49.93%) and net profit of 90 million yuan (+349.61%). The first quarter of 2024 also showed strong performance with revenue of 161 million yuan (+41.76%) and net profit of 32 million yuan (+153.27%) [3][24]. - The international business, particularly in aviation engine components, is growing rapidly, with a projected increase in LEAP engine shipments by 20-25% in 2024, which will drive further revenue growth [27]. - The company is expanding its production capacity and optimizing its product structure, which is expected to enhance profitability and operational efficiency [10][30]. Summary by Sections Financial Performance - In Q1 2024, the company reported a revenue of 161 million yuan, a 41.76% increase year-on-year, and a net profit of 32 million yuan, reflecting a 153.27% increase [3]. - For the full year 2023, the company achieved a revenue of 544 million yuan (+49.93%) and a net profit of 90 million yuan (+349.61%), marking the highest figures in the last five years [24][34]. Business Segments - The aviation products segment saw a revenue growth of 50.86%, while the medical products segment grew by 37.18%. The revenue contributions from aviation and medical products were 89.13% and 9.95%, respectively [6]. - The international engine components business generated 270 million yuan in revenue, a 68.27% increase, accounting for 49.67% of total revenue [7]. Operational Efficiency - The company improved its cash flow management, with net cash flow from operating activities reaching 121 million yuan, up from 52 million yuan in the previous year [6]. - The gross margin improved to 35.99% (+6.29 percentage points), and the net margin increased to 16.10% (+10.97 percentage points) due to enhanced production efficiency and product maturity [24][34]. Future Outlook - The company is expected to maintain strong growth, with projected revenues of 713 million yuan, 869 million yuan, and 1.017 billion yuan for 2024, 2025, and 2026, respectively [34]. - The expansion of production capacity and the introduction of new products are anticipated to support sustained revenue growth and profitability [10][30].